StreetInsider.com News Articles

This Is the Moment Everything Changed: Ascensia Launches Global Art and Photography Competition for World Diabetes Day

Thu, 06 Aug 2026 08:00:00 -0400

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

BASEL, Switzerland--(BUSINESS WIRE)-- Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TYO 6523), has launched its fifth annual This Is Diabetes Art & Photography Competition in support of World Diabetes Day 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

Global competition invites people to share the defining moment in their diabetes journey through original artwork and photography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806904499/en/

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805546533/en/

Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Wed, 05 Aug 2026 09:00:00 -0400

LEEDS, United Kingdom--(BUSINESS WIRE)-- A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision cancer diagnostics solutions. NHS is the UK's National Health Service.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805546533/en/

Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Wed, 05 Aug 2026 09:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805546533/en/

Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Wed, 05 Aug 2026 09:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805546533/en/

Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Wed, 05 Aug 2026 09:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805546533/en/

Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Wed, 05 Aug 2026 09:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805546533/en/

Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Wed, 05 Aug 2026 09:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805546533/en/

Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Wed, 05 Aug 2026 09:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805546533/en/

Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Wed, 05 Aug 2026 09:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805546533/en/

Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Wed, 05 Aug 2026 09:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805546533/en/

Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

Wed, 05 Aug 2026 09:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805546533/en/

Professor David Brettle, Chief Scientific Officer at Leeds Teaching Hospitals NHS